Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543907 · ClinicalTrials.gov registry record
Outcomes of a Deep Inferior Epigastric Perforator Flap Program
A clinical trial of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 977
- Enrollment target
- 1
- Study location
NCT00543907: Completed study of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.
NCT00543907 is a study of Breast Cancer that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 977 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00543907, a study of Breast Cancer, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 977 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.
Primary Outcome
complication rate
Conditions Studied
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 977 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-12 |
What the finished NCT00543907 record still lists
NCT00543907 is an observational study that tracks outcomes without assigning an intervention. The registered 977 participants enrollment target is mid-sized for trials with a published cap, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00543907 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00543907 about?
NCT00543907 is a clinical study titled "Outcomes of a Deep Inferior Epigastric Perforator Flap Program". The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.
What is the current status of trial NCT00543907?
This trial is currently completed. The enrollment target is 977 participants. The study started on 2007-09. Estimated completion is 2008-12.
What conditions does trial NCT00543907 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT00543907?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00543907 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00543907's enrollment target sits among peer trials
977 130th of 1224 higher than 1,095 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06988306 · 978 participants · NA
Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- NCT06820736 · 975 participants · NA
A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia